RXO ($RXO) is expected to release its quarterly earnings data on Thursday, August 7th before market open, per Finnhub. Analysts are expecting revenue of $1,454,424,048 and earnings of $0.02 per share.
You can see Quiver Quantitative's $RXO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
RXO Insider Trading Activity
RXO insiders have traded $RXO stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:
- THOMAS A SZLOSEK has made 2 purchases buying 16,200 shares for an estimated $250,228 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
RXO Hedge Fund Activity
We have seen 108 institutional investors add shares of RXO stock to their portfolio, and 140 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 7,306,537 shares (+374.1%) to their portfolio in Q1 2025, for an estimated $139,554,856
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,968,181 shares (+inf%) to their portfolio in Q1 2025, for an estimated $56,692,257
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 2,730,665 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $42,926,053
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 867,894 shares (-57.2%) from their portfolio in Q1 2025, for an estimated $16,576,775
- UBS GROUP AG removed 836,541 shares (-44.0%) from their portfolio in Q1 2025, for an estimated $15,977,933
- COOPER INVESTORS PTY LTD removed 765,534 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,034,194
- RIVULET CAPITAL, LLC added 750,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $14,325,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
RXO Analyst Ratings
Wall Street analysts have issued reports on $RXO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 04/24/2025
- Jefferies issued a "Buy" rating on 04/11/2025
- Barclays issued a "Overweight" rating on 04/02/2025
- Susquehanna issued a "Negative" rating on 03/26/2025
To track analyst ratings and price targets for RXO, check out Quiver Quantitative's $RXO forecast page.
RXO Price Targets
Multiple analysts have issued price targets for $RXO recently. We have seen 12 analysts offer price targets for $RXO in the last 6 months, with a median target of $18.0.
Here are some recent targets:
- Brian Ossenbeck from JP Morgan set a target price of $14.0 on 07/08/2025
- Ravi Shanker from Morgan Stanley set a target price of $21.0 on 07/07/2025
- Ariel Rosa from Citigroup set a target price of $18.0 on 05/21/2025
- Ken Hoexter from B of A Securities set a target price of $18.0 on 05/16/2025
- Thomas Wadewitz from UBS set a target price of $14.0 on 05/08/2025
- Jordan Alliger from Goldman Sachs set a target price of $18.0 on 05/08/2025
- J. Bruce Chan from Stifel set a target price of $14.0 on 05/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
